Related Experiment Videos
Neuropsychiatric systemic lupus erythematosus
Annals of the Rheumatic Diseases
|November 30, 1999
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cost-effectiveness of Interventions for Chronic Fatigue Syndrome or Myalgic Encephalomyelitis: A Systematic Review of Economic Evaluations.
Applied health economics and health policy·2021
Prospective evaluation of treatment response and disease reversibility of paediatric localized scleroderma (morphoea) to steroids and methotrexate using multi-modal imaging.
Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Treatment preference and recruitment to pediatric RCTs: A systematic review.
Contemporary clinical trials communications·2019
Efficacy of trans-nasal fiberendoscopic injection laryngoplasty with centrifuged autologous fat in the treatment of glottic insufficiency due to unilateral vocal fold paralysis.
Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale·2018
Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients.
Arthritis care & research·2017
Breast cancer in systemic lupus.
Lupus·2016
Zanubrutinib monotherapy for IgG4-related head and neck disease.
Annals of the rheumatic diseases·2026
Symmetrical dimethylarginine as the central antigenic determinant of anti-Smith autoantibodies in systemic lupus erythematosus.
Annals of the rheumatic diseases·2026
Development and validation of EULAR quality indicators for lupus nephritis: adherence trends and impact on clinical outcomes.
Annals of the rheumatic diseases·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026